Cervical tourniquet during cesarean section to reduce bleeding in morbidly adherent placenta: a pilot study

Omar F Altal, Suhair Qudsieh, Abeer Ben-Sadon, Assala Hatamleh, Adel Bataineh, Omar Halalsheh, Zouhir Amarin, Omar F Altal, Suhair Qudsieh, Abeer Ben-Sadon, Assala Hatamleh, Adel Bataineh, Omar Halalsheh, Zouhir Amarin

Abstract

Objective: To evaluate a modified surgical technique aiming to reduce bleeding and preserve fertility in morbidly adherent placenta by cervical tourniquet in cesarean sections.

Methods: The cesarean section operations and the cervical ligation approach were performed by a single expert consultant obstetrician. The general demographics and clinical characteristics for all participants were collected and studied.

Results: Eleven participants were involved. The uterus was preserved in nine patients, whereas two patients had hysterectomy. The mean blood loss was 1688.8 ml for patients whose uterus was preserved. The mean length of stay was 5.5 days.

Conclusion: Cervical ligation is a simple method that can be applied by junior and experienced obstetricians to preserve the uterus.

Keywords: cervical ligation; cesarean section; hysterectomy; placenta accreta; uterine artery ligation.

Conflict of interest statement

Financial & competing interests disclosure The authors have no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties. No writing assistance was utilized in the production of this manuscript.

© 2022 The Authors.

Figures

Figure 1.. The technique of cervical ligation…
Figure 1.. The technique of cervical ligation during cesarean section of patients with placenta accreta.
(A) Cord clamping. (B) Cervical ligation by Foley's catheter. (C) Cessation of bleeding after cervical ligation.

References

    1. Clark S, Belfort M, Dildy G, Herbst M, Meyers J, Hankins G. Maternal death in the 21st century: causes, prevention, and relationship to caesarean delivery. Am. J. Obstet. Gynecol. 199, 36.e1–5 (2008).
    1. WHO. Maternal Mortality in 2000. Estimates Developed by WHO, UNICEF and UNFPA. WHO, Geneva, Switzerland: (2004).
    1. Eggesbø T, Gjessing LK. Haemorrhage after caesarean delivery. Tidsskr. Nor. Legeforen. 120, 2864–2866 (2000) (in Norwegian, English summary).
    1. Naef RW, Chauhan SP, Chevalier SP, Roberts WE, Meydrech EF, Morrison JC. Prediction of hemorrhage at caesarean delivery. Obstet. Gynecol. 83, 923–926 (1994).
    1. Al-Zirqi I, Vangen S, Forsen L, Stray-Pedersen B. Prevalence and risk factors of severe obstetric haemorrhage. BJOG 115, 1265–1272 (2008).
    1. Bouvier-Colle MH, Péquignot F, Jouglas E. Mise au point sur la mortalité maternelle en France: fréquence, tendances et causes. J. Gynecol. Obstet. Biol. Reprod. 30, 768–775 (2001).
    1. Combs AA, Murphy EL, Laros RK. Factors associated with hemorrhage in cesarean deliveries. Obstet. Gynecol. 77, 77–82 (1991).
    1. Bergholt T, Stenderup JK, Vedsted-Jakobsen A, Helm P, Lenstrup C. Intraoperative surgical complications during caesarean section: an observational study of the incidence and risk factors. Acta Obstet. Gynecol. Scand. 82, 251–256 (2003).
    1. Oyelese Y, Smulian JC. Placenta previa, placenta accreta, and vasa previa. Obstet. Gynecol. 107, 927–941 (2006).
    1. Norman J. Haemorrhage. Centre for Maternal and Child Enquiries (CMACE). In: Saving mothers’lives: reviewing maternal deaths to make motherhood safer: 2006–2008. The Eighth Report on Confidential Enquiries into Maternal Deaths in the United Kingdom. BJOG. 118(Suppl. 1), 71–76 (2011).
    1. Onwere C, Gurol-Urganci I, Cromwell DA, Mahmood TA, Templeton A, van der Meulen JH. Maternal morbidity associated with placenta praevia among women who had elective caesarean section. Eur. J. Obstet. Gynecol. Reprod. Biol. 159, 62–66 (2011).
    1. Esakoff TF, Sparks TN, Kaimal AJ et al. Diagnosis and morbidity of placenta accreta. Ultrasound Obstet. Gynecol. 37, 324–327 (2011).
    1. Higgins MF, Monteith C, Foley M, O’Herlihy C. Real increasing incidence of hysterectomy for placenta accreta following previous caesarean section. Eur. J. Obstet. Gynecol. Reprod. Biol. 171, 54–56 (2013).
    1. Silver RM, Landon MB, Rouse DJ et al. Maternal morbidity associated with multiple repeat cesarean deliveries. Obstet. Gynecol. 107, 1226–1232 (2006).
    1. Committee opinion no. 529: placenta accreta. Committee opinion no. 529: placenta accreta. Committee on Obstetric Practice. Obstet. Gynecol. 120(1), 207–211 (2012).
    1. O'Brien D, Babiker E, O'Sullivan O et al. Prediction of peripartum hysterectomy and end organ dysfunction in major obstetric haemorrhage. Eur. J. Obstet. Gynecol. Reprod. Biol. 153, 165–169 (2010).
    1. Garmi G, Salim R. Epidemiology, etiology, diagnosis, and management of placenta accreta. Obstet. Gynecol. Int. 2012, 873929 (2012).
    1. Usta IM, Hobeika EM, Musa AA, Gabriel GE, Nassar AH. Placenta previa-accreta: risk factors and complications. Am. J. Obstet. Gynecol. 193, 1045–1049 (2005).
    1. Committee on Obstetric Practice. Committee opinion no. 529: placenta accreta. Obstet. Gynecol. 120(1), 207–211 (2012).
    1. Mogos MF, Salemi JL, Ashley M, Whiteman VE, Salihu HM. Recent trends in placenta accreta in the United States and its impact on maternal-fetal morbidity and healthcare-associated costs, 1998–2011. J. Matern. Fetal Neonatal Med. 29, 1077–1082 (2016).
    1. Eshkoli T, Weintraub AY, Sergienko R, Sheiner E. Placenta accreta: risk factors, perinatal outcomes, and consequences for subsequent births. Am. J. Obstet. Gynecol. 208, 219. e1–e7 (2013).
    1. Bowman ZS, Eller AG, Bardsley TR, Greene T, Varner MW, Silver RM. Risk factors for placenta accreta: a large prospective cohort. Am. J. Perinatol. 31, 799–804 (2014).
    1. Baldwin HJ, Patterson JA, Nippita TA et al. Antecedents of abnormally invasive placenta in primiparous women: risk associated with gynecologic procedures. Obstet. Gynecol. 131, 227–233 (2018).
    1. Garmi G, Salim R. Epidemiology, etiology, diagnosis, and management of placenta accreta. Obstet. Gynecol. Int. 2012, 873929 (2012).
    1. Silver RM, Landon MB, Rouse DJ et al. Maternal morbidity associated with multiple repeat cesarean deliveries. National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. Obstet. Gynecol. 107, 1226–1232 (2006).
    1. Kupferminc MJ, Tamura RK, Wigton TR, Glassenberg R, Socol ML. Placenta accreta is associated with elevated maternal serum alpha-fetoprotein. Obstet. Gynecol. 82, 266–269 (1993).
    1. Lyell DJ, Faucett AM, Baer RJ et al. Maternal serum markers, characteristics and morbidly adherent placenta in women with previa. J. Perinatol. 35, 570–574 (2015).
    1. Eller AG, Porter TF, Soisson P, Silver RM. Optimal management strategies for placenta accreta. BJOG 116, 648–654 (2009).

    2. • This article describes many procedures for the management of placenta accreta.

    1. Tan CH, Tay KH, Sheah K et al. Perioperative endovascular internal iliac artery occlusion balloon placement in management of placenta accreta. AJR Am. J. Roentgenol. 189, 1158–1163 (2007).
    1. Courbière B, Bretelle F, Porcu G, Gamerre M, Blanc B. Conservative treatment of placenta accreta. J. Gynecol. Obstet. Biol. Reprod. (Paris) 32, 549–554 (2003).
    1. Sentilhes L, Ambroselli C, Kayem G et al. Maternal outcome after conservative treatment of placenta accreta. Obstet. Gynecol. 115, 526–534 (2010).
    1. Clausen C, Lonn L, Langhoff-Roos J. Management of placenta percreta: a review of published cases. Acta Obstet. Gynecol. Scand. 93, 138–143 (2014).
    1. Fox KA, Shamshirsaz A, Carusi D et al. Conservative management of morbidly adherent placenta: expert review. Am. J. Obstet. Gynecol. 213, 755–760 (2015).
    1. Dilauro MD, Dason S, Athreya S. Prophylactic balloon occlusion of internal iliac arteries in women with placenta accreta: literature review and analysis. Clin. Radiol. 67, 515–520 (2012).
    1. D’Souza DL, Kingdom JC, Amsalem H et al. Conservative management of invasive placenta using combined prophylactic internal iliac artery balloon occlusion and immediate postoperative uterine artery embolization. Can. Assoc. Radiol. J. 66, 179–184 (2015).
    1. Bishop S, Butler K, Monaghan S et al. Multiple complications following the use of prophylactic internal iliac artery balloon catheterisation in a patient with placenta percreta. Int. J. Obstet. Anesth. 20, 70–73 (2011).
    1. Shehata A. Uterine sparing techniques in placenta accreta. Obstet. Gynecol. Int. J. 5, 00143 (2016).
    1. Shazly SA, Badee AY, Ali MK. The use of multiple 8 compression suturing as a novel procedure to preserve fertility in patients with placenta accreta: case series. Aust. N. Z. J. Obstet. Gynaecol. 52, 395–399 (2012).
    1. Salvat J, Schmidt MH, Guilbert M, Martino A. Vascular ligation for severe obstetrical hemorrhage: review of the literature. J. Gynecol. Obstet. Biol. Reprod. (Paris) 31, 629–639 (2002).
    1. Gungor T, Simsek A, Ozdemir AO et al. Surgical treatment of intractable postpartum hemorrhage and changing trends in modern obstetric perspective. Arch. Gynecol. Obstet. 280, 351–355 (2009).
    1. Joshi VM, Otiv SR, Majumder R, Nikam YA, Shrivastava M. Internal iliac artery ligation for arresting postpartum hemorrhage. BJOG 114, 356–361 (2007).
    1. Doumouchtsis SK, Papageorghiou AT, Arulkumaran S. Systematic review of conservative management of postpartum hemorrhage: what to do when medical treatment fails. Obstet. Gynecol. Surv. 62, 540–547 (2007).
    1. Dawlatly B, Wong I, Khan K, Agnihotri S. Using the cervix to stop bleeding in a woman with placenta accreta: a case report. BJOG 114, 502–504 (2007).
    1. El Gelany SAA, Abdelraheim AR, Mohammed MM et al. The cervix as a natural tamponade in postpartum hemorrhage caused by placenta previa and placenta previa accreta: a prospective study. BMC Pregnancy Childbirth 15, 295 (2015).

    2. • This article describes the cervical tourniquet in placenta accreta.

    1. Madny E, Atwa K, Eid A, Farag M. Use of cervical inversion technique as a tamponade to control postpartum hemorrhage caused by placenta previa and placenta previa focal accreta. Evid. Based Women Health J. 9, 344–348 (2019).
    1. Rubin IC. The pericervical broad ligament tourniquet for preventive hemostasis in myomectomy. Obstet. Gynecol. 1, 668–671 (1953).
    1. Kotsuji F, Nishijima K, Kurokawa T et al. Transverse uterine fundal incision for placenta praevia with accreta, involving the entire anterior uterine wall: a case series. BJOG 120, 1144–1149 (2013).
    1. Meng JL, Gong WY, Wang S, Ni XJ, Zuo CT, Gu YZ. Two-tourniquet sequential blocking as a simple intervention for hemorrhage during cesarean delivery for placenta previa accreta. Int. J. Gynaecol. Obstet. 138, 361–362 (2017).
    1. Shmakov RG, Vinitskiy AA, Chuprinin VD, Yarotskaya EL, Sukhikh GT. Alternative approaches to surgical hemostasis in patients with morbidly adherent placenta undergoing fertility-sparing surgery. J. Matern. Fetal Neonatal Med. 32, 2042–2048 (2019).
    1. Palacios-Jaraquemada JM, Fiorillo A, Hamer J, Martinez M, Bruno C. Placenta accreta spectrum: a hysterectomy can be prevented in almost 80% of cases using a resective-reconstructive technique. J. Matern. Fetal Neonatal Med. 26, 1–8 (2020).

Source: PubMed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe